The ability to jump-start OXPHOS as soon as the cells are provided with oxygen provides an additional metabolic flexibility that may enable FLT3-ITD-positive AML cells to rapidly resume their aggressive growth properties when faced with such demanding variations of oxygen availability in AML bone marrow. The gene discussed is FLT3; the disease is acute myeloid leukemia.